Beckman Coulter

Beckman Coulter is a manufacturer of clinical diagnostic products that specialize in simplifying, automating, and innovating complex biomedical testing. With over 275,000 systems in operation worldwide, the company serves both Diagnostics and Life Sciences laboratories across all seven continents. For more than 75 years, Beckman Coulter has focused on enhancing the productivity of medical professionals and scientists by providing critical information that improves patient health. Their product portfolio includes diagnostic solutions for various health concerns, including sepsis, cardiovascular disease, reproductive health, anemia, and drug monitoring, thereby enabling healthcare providers to gain deeper insights and accelerate patient care.

5 past transactions

StoCastic

Acquisition in 2022
Stocastic is a healthcare software company founded in 2015 and based in Towson, Maryland. The company specializes in developing enterprise software that enhances the efficiency of healthcare organizations while benefiting patients. Its software solutions focus on improving operational performance, clinical workflows, and teamwork within healthcare systems. By utilizing consulting bundles, Stocastic aims to implement organizational best practices that lead to smoother and more affordable care for patients.

Lumigen

Acquisition in 2006
Lumigen specializes in the manufacture and marketing of chemiluminescent compounds and reagents, primarily serving the clinical immunodiagnostics market. The company's products include essential tools for life science research and medical diagnostics, such as those used in western blotting, alkaline phosphatase, horseradish peroxidase, and homogeneous immunoassays. These offerings play a crucial role in various applications, including human identity testing and advanced research in life sciences.

Diagnostic Systems Laboratories

Acquisition in 2005
Diagnostic Systems Laboratories manufactures and distributes clinical and research diagnostics.

Agencourt Bioscience

Acquisition in 2005
Agencourt Bioscience Corporation provides nucleic acid purification products and genomic services for life science research in the United States and internationally. It offers DNA purification and RNA purification solutions. The company’s products include solid phase reversible immobilization (SPRI) reagents; a PCR1 purification system that delivers DNA; a dye-terminator removal process system; a paramagenetic bead-based plasmid purification system; and a genomic DNA isolation reagent kit. Its products also include Agencourt FormaPure system that provides a process for extracting nucleic acid from formalin-fixed and paraffin-embedded tissue samples; a tissue RNA extraction technology; accessories; and a suite of automation methods for SPRI paramagnetic bead-based reagents. In addition, the company offers DNA sequencing, resequencing and SNP discovery, library construction, bioinformatics, and sequencing pipeline services. It serves biotechnology, pharmaceutical, government, and academic research laboratories. Agencourt Bioscience Corporation has strategic alliances with Affymetrix Inc.; Amplicon Express, Inc.; Seradyn, Inc.; Invitrogen, Corp.; Integrated Genomics, Inc.; and Ambion, Inc. The company was founded in 2000 and is headquartered in Beverly, Massachusetts. It has offices in Australia, Canada, China, Eastern Europe, the Middle East, North Africa, France, Germany, Hong Kong, Italy, Japan, Mexico, the Netherlands, Singapore, South Africa, Sub-Saharan Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, the United Kingdom, and the United States. As of June 30, 2005, Agencourt Bioscience Corporation was a subsidiary of Beckman Coulter, Inc.

Q3DM

Acquisition in 2003
Q3DM specializes in quantitative 3-dimensional microscopy, offering a High Throughput Microscopy (HTM) platform designed to enhance drug discovery processes. The company's innovative products and services focus on cell-based imaging, addressing challenges associated with automating high-resolution imaging. By combining high content screening with rapid analysis, Q3DM enables researchers to obtain statistically significant results and gain insights into complex biological processes, thereby facilitating advancements in drug discovery.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.